NYSEAMERICAN : AIM
AIM ImmunoTech Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.164 USD (Oct 30, 2026, 9:30 AM EDT) · Market cap 4.99M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
AIM ImmunoTech Inc. (AIM) reported revenue of 95.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 95.00K | 88.00K | 170.00K | 202.00K | 141.00K | 135.00K |
| Cost of Revenue | 117.00K | 128.00K | 31.00K | 42.00K | 850.00K | |
| Gross Profit | -22.00K | -40.00K | 139.00K | 160.00K | 141.00K | -715.00K |
| Selling, General & Admin | 8.71M | 8.07M | 14.16M | 21.64M | 13.29M | 8.67M |
| Research & Development | 2.41M | 3.55M | 5.75M | 10.44M | 6.77M | 7.67M |
| Operating Expenses | 11.12M | 11.62M | 19.91M | 32.08M | 20.06M | 16.34M |
| Operating Income | -11.14M | -11.66M | -19.77M | -31.92M | -19.92M | -17.06M |
| Interest Expense | -1.17M | -812.00K | -585.00K | -67.00K | ||
| Interest & Investment Income | 150.00K | 142.00K | 285.00K | 1.07M | 629.00K | |
| Other Non Operating Income (Expenses) | -5.15M | -4.68M | 2.85M | 1.67M | 1.52M | 2.46M |
| EBT Excluding Unusual Items | -17.31M | -17.02M | -17.23M | -29.18M | -17.77M | -14.66M |
| Gain (Loss) on Sale of Investments | -3.00K | 17.00K | -93.00K | 200.00K | -1.68M | -201.00K |
| Gain (Loss) on Sale of Assets | 18.00K | 3.00K | 216.00K | |||
| Asset Writedown | -1.78M | |||||
| Other Unusual Items | 3.04M | 3.04M | -2.70M | |||
| Pretax Income | -14.27M | -13.96M | -17.32M | -28.96M | -19.45M | -19.13M |
| Net Income | -14.27M | -13.96M | -17.32M | -28.96M | -19.45M | -19.13M |
| Net Income to Common | -14.27M | -13.96M | -17.32M | -28.96M | -19.45M | -19.13M |
| Shares Outstanding (Basic) | 6.66M | 1.62M | 560.17K | 486.34K | 480.95K | 473.87K |
| Shares Outstanding (Diluted) | 6.66M | 1.62M | 560.17K | 486.34K | 480.95K | 473.87K |
| EPS (Basic) | -2.14 | -8.62 | -30.92 | -59.55 | -40.43 | -40.36 |
| EPS (Diluted) | -2.14 | -8.62 | -30.92 | -59.55 | -40.43 | -40.36 |
| Free Cash Flow | -14.37M | -10.96M | -14.91M | -21.27M | -16.19M | -14.01M |
| Free Cash Flow Per Share | -2.16 | -6.77 | -26.61 | -43.73 | -33.67 | -29.56 |
| Gross Margin | -23.16% | -45.45% | 81.77% | 79.21% | 100.00% | |
| Operating Margin | -11,724.21% | -13,254.54% | -11,630.59% | -15,800.00% | -14,129.79% | -12,636.30% |
| Profit Margin | -15,021.05% | -15,861.36% | -10,188.24% | -14,337.62% | -13,790.78% | -14,168.15% |
| Free Cash Flow Margin | -15,130.53% | -12,451.14% | -8,768.24% | -10,528.22% | -11,485.11% | -10,374.81% |
| EBITDA | -10.73M | -11.45M | -19.53M | -31.68M | -19.67M | -16.28M |
| D&A For EBITDA | 404.00K | 210.00K | 246.00K | 238.00K | 256.00K | 775.00K |
| EBIT | -11.14M | -11.66M | -19.77M | -31.92M | -19.92M | -17.06M |
| Revenue as Reported | 95.00K | 88.00K | 170.00K | 202.00K | 141.00K | 135.00K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 9.90M | 2.98M | 1.70M | 5.44M | 27.05M | 32.09M |
| Short-Term Investments | 64.00K | 62.00K | 2.28M | 7.63M | 7.14M | 16.18M |
| Cash & Short-Term Investments | 9.96M | 3.05M | 3.98M | 13.07M | 34.19M | 48.27M |
| Other Receivables | 7.00K | 1.18M | 1.68M | 1.64M | ||
| Receivables | 7.00K | 1.18M | 1.68M | 1.64M | ||
| Prepaid Expenses | 468.00K | 241.00K | 199.00K | 302.00K | 455.00K | 304.00K |
| Total Current Assets | 10.43M | 3.29M | 4.18M | 14.56M | 36.32M | 50.21M |
| Property, Plant & Equipment | 314.00K | 449.00K | 726.00K | 824.00K | 1.02M | 4.20M |
| Other Intangible Assets | 1.71M | 1.66M | 2.59M | 2.31M | 1.94M | 1.97M |
| Long-Term Deferred Tax Assets | 1.60M | 1.12M | ||||
| Other Long-Term Assets | 271.00K | 377.00K | 1.11M | 84.00K | 84.00K | 1.32M |
| Total Assets | 12.73M | 5.78M | 8.61M | 19.38M | 40.49M | 57.70M |
| Accounts Payable | 480.00K | 1.63M | 6.38M | 6.44M | 377.00K | 198.00K |
| Accrued Expenses | 586.00K | 795.00K | 606.00K | 1.99M | 806.00K | 438.00K |
| Current Portion of Long-Term Debt | 3.62M | 3.55M | 2.31M | |||
| Current Portion of Leases | 259.00K | 250.00K | 239.00K | 223.00K | 178.00K | 37.00K |
| Total Current Liabilities | 4.95M | 6.22M | 9.54M | 8.65M | 1.36M | 673.00K |
| Long-Term Debt | 927.00K | |||||
| Long-Term Leases | 41.00K | 170.00K | 395.00K | 495.00K | 659.00K | 112.00K |
| Other Long-Term Liabilities | 8.24M | 35.00K | ||||
| Total Liabilities | 4.99M | 15.56M | 9.93M | 9.15M | 2.02M | 820.00K |
| Common Stock | 29.00K | 3.00K | 1.00K | 49.00K | 48.00K | 48.00K |
| Additional Paid-In Capital | 455.31M | 431.00M | 425.50M | 419.00M | 418.27M | 417.22M |
| Retained Earnings | -447.60M | -440.79M | -426.83M | -409.51M | -380.55M | -361.10M |
| Total Common Equity | 7.74M | -9.78M | -1.32M | 9.54M | 37.77M | 56.16M |
| Shareholders' Equity | 7.74M | -9.78M | -1.32M | 10.23M | 38.47M | 56.88M |
| Total Liabilities & Equity | 12.73M | 5.78M | 8.61M | 19.38M | 40.49M | 57.70M |
| Total Debt | 3.92M | 4.90M | 2.94M | 718.00K | 837.00K | 149.00K |
| Net Cash (Debt) | 6.04M | -1.85M | 1.04M | 12.35M | 33.35M | 48.12M |
| Net Cash Per Share | 0.91 | -1.14 | 1.85 | 25.40 | 69.35 | 101.54 |
| Filing Date Shares Outstanding | 30.44M | 8.15M | 723.62K | 499.51K | 484.56K | 480.43K |
| Total Common Shares Outstanding | 28.99M | 3.07M | 655.92K | 491.52K | 481.32K | 480.43K |
| Working Capital | 5.49M | -2.93M | -5.36M | 5.90M | 34.96M | 49.54M |
| Book Value Per Share | 0.27 | -3.19 | -2.02 | 19.42 | 78.48 | 116.90 |
| Tangible Book Value | 6.03M | -11.44M | -3.92M | 7.23M | 35.83M | 54.19M |
| Tangible Book Value Per Share | 0.21 | -3.73 | -5.97 | 14.71 | 74.44 | 112.80 |
| Land | 3.90M | |||||
| Machinery | 1.47M | 1.47M | 1.47M | 1.45M | 2.23M | 2.35M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -14.27M | -13.96M | -17.32M | -28.96M | -19.45M | -19.13M |
| Depreciation & Amortization | 404.00K | 210.00K | 246.00K | 238.00K | 256.00K | 775.00K |
| Other Amortization | 552.00K | 552.00K | 301.00K | 47.00K | ||
| Loss (Gain) From Sale of Assets | -18.00K | -216.00K | ||||
| Asset Writedown & Restructuring Costs | 547.00K | 1.14M | 48.00K | 14.00K | 1.78M | |
| Loss (Gain) From Sale of Investments | 1.00K | -17.00K | 93.00K | -200.00K | 1.68M | 47.00K |
| Stock-Based Compensation | 60.00K | 686.00K | 243.00K | 954.00K | 1.57M | |
| Other Operating Activities | 2.44M | 1.94M | 762.00K | 287.00K | -518.00K | 267.00K |
| Change in Accounts Receivable | -7.00K | 34.00K | ||||
| Change in Accounts Payable | -3.95M | -1.71M | -60.00K | 6.07M | 179.00K | -185.00K |
| Change in Other Net Operating Assets | -92.00K | 841.00K | 356.00K | 1.06M | 787.00K | 1.05M |
| Operating Cash Flow | -14.37M | -10.96M | -14.89M | -21.27M | -16.11M | -13.96M |
| Capital Expenditures | -18.00K | -86.00K | -41.00K | |||
| Sale of Property, Plant & Equipment | 47.00K | 3.90M | 245.00K | |||
| Sale (Purchase) of Intangibles | -242.00K | -378.00K | -538.00K | -585.00K | -185.00K | -592.00K |
| Investment in Securities | 294.00K | 2.23M | 5.26M | -294.00K | 7.36M | -243.00K |
| Investing Cash Flow | 52.00K | 1.85M | 4.71M | -832.00K | 10.99M | -631.00K |
| Long-Term Debt Issued | 2.75M | 2.50M | ||||
| Long-Term Debt Repaid | -660.00K | -251.00K | -4.85M | |||
| Net Debt Issued (Repaid) | 1.02M | 2.09M | 2.25M | -4.85M | ||
| Issuance of Common Stock | 15.41M | 984.00K | 892.00K | 485.00K | 80.00K | 13.04M |
| Other Financing Activities | 7.31M | 7.31M | 3.30M | |||
| Financing Cash Flow | 23.75M | 10.39M | 6.44M | 485.00K | 80.00K | 8.19M |
| Net Cash Flow | 9.42M | 1.28M | -3.74M | -21.61M | -5.04M | -6.41M |
| Free Cash Flow | -14.37M | -10.96M | -14.91M | -21.27M | -16.19M | -14.01M |
| Free Cash Flow Margin | -15,130.53% | -12,451.14% | -8,768.24% | -10,528.22% | -11,485.11% | -10,374.81% |
| Free Cash Flow Per Share | -2.16 | -6.77 | -26.61 | -43.73 | -33.67 | -29.56 |
| Levered Free Cash Flow | -14.06M | -11.97M | -12.20M | -12.16M | -11.15M | -9.77M |
| Unlevered Free Cash Flow | -13.88M | -12.01M | -12.13M | -12.16M | -11.15M | -9.78M |
| Cash Interest Paid | 247.00K | 247.00K | ||||
| Change in Working Capital | -4.04M | -878.00K | 296.00K | 7.13M | 966.00K | 895.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 4.89M | 3.22M | 12.63M | 21.49M | 15.00M | 44.02M |
| Enterprise Value | -1.15M | 3.15M | 8.83M | 494.40K | -20.17M | -8.77M |
| Last Close Price | 0.15 | 1.13 | 19.78 | 43.95 | 31.16 | 91.91 |
| PS Ratio | 51.53 | 36.64 | 74.28 | 106.36 | 106.36 | 326.08 |
| PB Ratio | 0.58 | -0.33 | -9.55 | 2.10 | 0.39 | 0.77 |
| P/TBV Ratio | 0.81 | 2.97 | 0.42 | 0.81 | ||
| EV/Sales Ratio | 35.83 | 51.92 | 2.45 | |||
| Debt / Equity Ratio | 0.51 | -0.50 | -2.23 | 0.07 | 0.02 | 0.00 |
| Net Debt / Equity Ratio | -0.78 | -0.19 | 0.78 | -1.21 | -0.87 | -0.85 |
| Net Debt / EBITDA Ratio | 0.56 | -0.16 | 0.05 | 0.39 | 1.70 | 2.96 |
| Net Debt / FCF Ratio | 0.42 | -0.17 | 0.07 | 0.58 | 2.06 | 3.44 |
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Quick Ratio | 2.02 | 0.49 | 0.42 | 1.65 | 26.35 | 74.16 |
| Current Ratio | 2.11 | 0.53 | 0.44 | 1.68 | 26.69 | 74.61 |
| Return on Equity (ROE) | -2,382.30% | -388.69% | -118.93% | -40.79% | -32.37% | |
| Return on Assets (ROA) | -82.58% | -101.32% | -88.30% | -66.64% | -25.36% | -17.44% |
| Return on Capital Employed (ROCE) | -143.10% | 2,638.90% | 2,132.90% | -297.50% | -50.90% | -29.90% |
| Earnings Yield | -1,332.81% | -432.94% | -137.15% | -134.80% | -129.66% | -43.45% |
| FCF Yield | -293.64% | -339.86% | -118.04% | -98.98% | -107.98% | -31.82% |
| Buyback Yield / Dilution | -894.51% | -188.95% | -15.18% | -1.12% | -1.49% | -48.67% |